180 related articles for article (PubMed ID: 38662718)
21. Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions.
Suhonen V; Siiskonen H; Suni M; Rummukainen J; Mannermaa A; Harvima IT
Eur J Dermatol; 2022 Apr; 32(2):187-194. PubMed ID: 35866898
[TBL] [Abstract][Full Text] [Related]
22. Progression of skin lesions from normal skin to squamous cell carcinoma.
Krouse RS; Alberts DS; Prasad AR; Yozwiak M; Bartels HG; Liu Y; Bartels PH
Anal Quant Cytol Histol; 2009 Feb; 31(1):17-25. PubMed ID: 19320189
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma.
Olsen J; Themstrup L; De Carvalho N; Mogensen M; Pellacani G; Jemec GB
Photodiagnosis Photodyn Ther; 2016 Dec; 16():44-49. PubMed ID: 27519350
[TBL] [Abstract][Full Text] [Related]
24. Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma.
Majidian M; Anderson J; Rock J; Ai R; Whitaker J; Howell M; Moy R
J Drugs Dermatol; 2023 May; 22(5):440-444. PubMed ID: 37133468
[TBL] [Abstract][Full Text] [Related]
25. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence--remission sensoring of skin tumours: preliminary results.
Wollina U; Nelskamp C; Scheibe A; Fassler D; Schmidt WD
Skin Res Technol; 2007 Nov; 13(4):463-71. PubMed ID: 17908200
[TBL] [Abstract][Full Text] [Related]
28. [Management of non melanoma skin cancer by the general practitioner].
Lam Hoai X; Trakatelli M; Ahbib S; Richert B
Rev Med Brux; 2016; 37(4):212-220. PubMed ID: 28525218
[TBL] [Abstract][Full Text] [Related]
29. Histology of melanoma and nonmelanoma skin cancer.
Müller CS
Adv Exp Med Biol; 2014; 810():141-59. PubMed ID: 25207364
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
32. [Early detection of skin cancer].
Treiber N; Huber MA; Scharffetter-Kochanek K; Schneider LA
MMW Fortschr Med; 2014 Mar; 156(4):37-40. PubMed ID: 24908774
[No Abstract] [Full Text] [Related]
33. Normal-subtracted preprocessing of Raman spectra aiming to discriminate skin actinic keratosis and neoplasias from benign lesions and normal skin tissues.
Silveira L; Pasqualucci CA; Bodanese B; Pacheco MTT; Zângaro RA
Lasers Med Sci; 2020 Jul; 35(5):1141-1151. PubMed ID: 31853808
[TBL] [Abstract][Full Text] [Related]
34. MART-1-labeled melanocyte density and distribution in actinic keratosis and squamous cell cancer in situ: Pagetoid melanocytes are a potential source of misdiagnosis as melanoma in situ.
Fix WC; Yun SJ; Groft MacFarlane CM; Jambusaria A; Elenitsas R; Chu E; Etzkorn JR; Sobanko JF; Shin TM; Miller CJ
J Cutan Pathol; 2018 Oct; 45(10):734-742. PubMed ID: 29943494
[TBL] [Abstract][Full Text] [Related]
35. New and current preventive treatment options in actinic keratosis.
Arenberger P; Arenbergerova M
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940
[TBL] [Abstract][Full Text] [Related]
36. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
38. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults.
Foote JA; Harris RB; Giuliano AR; Roe DJ; Moon TE; Cartmel B; Alberts DS
Int J Cancer; 2001 Jan; 95(1):7-11. PubMed ID: 11241303
[TBL] [Abstract][Full Text] [Related]
39. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
40. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
